It has slowed down digestion to suppress your appetite and regulate blood sugar levels
Second, tracking creates a comprehensive record that can identify patterns between medication timing, dietary choices, physical activity, and outcomes
GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management
The consistency across different populations and healthcare systems strengthens the evidence for causation, particularly given the temporal relationship between drug initiation and NAION onset with many cases occurring within months of starting semaglutide
Rodent studies Eight preclinical studies investigated the effect of supplementation with a combination of different nutrients on ES-induced behavioral deficits, out of which six studies found an effect of ES on at least one of the behavioral domains investigated and those will be described below
Both medications slow digestion, reduce appetite, and promote insulin production